Imagine you have to make a speech, but instead of looking down at your notes, the words scroll in front of your eyes, whichever direction you look in.
That’s just one of many features the makers of smart contact lenses promise will be available in the future.
Read the full article:
KEY TAKEAWAYS
Virtual and augmented reality have been through some false starts. But this time is different.
Rapid advances in AR have made doctors the first superhumans, and these abilities are only growing.
As AR hits the consumer market, it will sell superpowers to all of us. AR eyewear will soon replace the smartphone as our interface for digital content.
Click below for the full article:
https://bigthink.com/the-future/ar-will-make-us-superhumans/
The Neopal platform is exclusive and accessible only by registered users in the Middle East
Drs can now get trained on different Aesthetic, Dermatology and Surgery procedures remotely, using state of the art Hippo technology which enables the trainer to accompany the Dr during the procedure. This allows remote proctoring, evaluation and calibration of procedures and competencies.
Take a sneak peak:
The European Medicines Agency (EMA) has started reviewing the evidence for a new COVID-19 vaccine, known as PHH-1V. This protein-based vaccine is being developed by HIPRA Human Health S.L.U. as a booster vaccine for adults who have already been fully vaccinated with an mRNA or an adenovirus COVID-19 vaccine, or both.
Preliminary results from laboratory and clinical studies suggest that PHH-1V may be effective as Comirnaty against SARS-CoV-2, including against variants of concern.
The start of the review means that the EMA will evaluate data as they become available, to decide if the benefits of the vaccine outweigh the risks. The rolling review will continue until enough evidence is available for a formal marketing authorisation application.
PHH-1V contains two versions of the receptor-binding domain of the spike protein: one version corresponds to the spike protein of the Alpha variant, and the other corresponds to that of the Beta variant.
In addition to PHH-1V, the EMA is currently carrying out rolling reviews on three other vaccines; the inactivated Vero Cell vaccine from Sinovac, the Sputnik V Gam-COVID-Vac developed by Russia’s Gamaleya National Centre of Epidemiology and Microbiology, and VLA2001, which is being developed by Valneva.
Emblation Limited, the global leader in medical microwave technology, is delighted to announce the launch of Swift® Microwave Therapy in the Middle East. Working in close partnership with industry expert Elie Helou from Neomed Trading, Swift® is now available in the UAE, with further market launches expected across the region over the next 6 months. read full news here:
https://www.prweb.com/releases/2022/3/prweb18563236.htm
According to a recently published study which has been published in JAMA Network Open, consuming potent doses of Vitamin C (ascorbic acid) and Zinc have not been found to have any sort of effect on COVID recovery or lessening of symptoms. Read full article:
https://timesofindia.indiatimes.com/life-style/health-fitness/health-news/coronavirus-vitamin-c-zinc-do-not-alleviate-covid-symptoms-finds-study/photostory/80921860.cms
Top Companies operating in Medical Aesthetics Market profiled in the MRFR report include Allergan plc (Ireland), Merz Pharma GmbH & Co. KGaA (Germany), Lumenis (Israel), Hologic (U.S.), Galderma Laboratories (Switzerland), Bausch Health (U.S.), Anika Therapeutics Inc. (U.S.), Cutera, Inc. (U.S.), Alma Lasers Ltd. (Israel), Syneron Medical Ltd (U.S.)
Browse In-depth Market Research Report (210 Pages) on Medical Aesthetics: https://www.marketresearchfuture.com/reports/medical-aesthetics-market-6807
